Hyperandrogenism and insulin resistance synergistically contribute to hepatic steatosis and inflammation in a female rat model of PCOS.
Answers are grounded in this paper and cite their sources.
Does not support changing PCOS care; leaves open hyperandrogenism's role in human hepatic steatosis.
// Yuehui Zhang 1, 2 , Fanci Meng 1 , Xiaoyan Sun 1 , Xue Sun 1 , Min Hu 2 , Peng Cui 2, 3, 4 , Edvin Vestin 2 , Xin Li 2, 5, 6 , Wei Li 1 , Xiao-Ke Wu 1 , John-Olov Jansson 2 , Linus R. Shao 2 and Håkan Billig 2 1 Department of Obstetrics and Gynecology, Key Laboratory and Unit of Infertility in Chinese Medicine, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, 150040 Harbin, China 2 Department of Physiology/Endocrinology, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, 40530 Gothenburg, Sweden 3 Department of Integrative Medicine and Neurobiology, State Key Lab of Medical Neurobiology, Shanghai Medical College and Institute of Acupuncture Research (WHO Collaborating Center for Traditional Medicine), Institute of Brain Science, Fudan University, 200032 Shanghai, China 4 Institute of Integrative Medicine of Fudan University, 200032 Shanghai, China 5 Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, 200011 Shanghai, China 6 Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, 200011 Shanghai, China Correspondence to: Yuehui Zhang, email: chizishui-04@163.com Linus R. Shao, email: linus.r.shaou@fysiologi.gu.se Keywords: PCOS; hyperandrogenism; insulin resistance; hepatic metabolism; inflammation Received: November 21, 2017 Accepted: January 25, 2018 Epub: February 09, 2018 Published: April 06, 2018 ABSTRACT Women with polycystic ovary syndrome (PCOS) are at high risk for nonalcoholic fatty liver disease (NAFLD). While insulin resistance is a common trait for both PCOS and NAFLD, hyperandrogenism is also considered to be a key factor contributing to PCOS, and the molecular mechanisms behind the interactions between insulin resistance and hyperandrogenism in the female liver remain largely unexplored. Using chronic treatment with insulin and/or human chorionic gonadotropin (hCG), we showed that all female rats with different treatments induced imbalance between de novo lipogenesis and mitochondrial β-oxidation via the Pparα/β–Srebp1/2–Acc1 axis, resulting in varying degrees of hepatic steatosis. Given the fact that hepatic lipid metabolism and inflammation are tightly linked processes, we found that hCG-induced hyperandrogenic rats had strongly aggravated hepatic inflammation. Further mechanistic investigations revealed that dysregulation of the IRS–PI3K–Akt signaling axis that integrated aberrant inflammatory, apoptotic and autophagic responses in the liver was strongly associated with hyperandrogenism itself or combined with insulin resistance. Additionally, we found that hCG-treated and insulin+hCG-induced rats developed visceral adipose tissue inflammation characterized by the presence of “crown like” structure and increased inflammatory gene expression. Because a more pronounced hepatic steatosis, inflammatory responses, and hepatocyte cell damage were observed in insulin+hCG-induced PCOS-like rats, our finding suggest that NAFLD seen in PCOS patients is dependent of hyperandrogenism and insulin resistance.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: